Erlotinib is used to treat advanced non-small cell lung cancer (NSCLC), an aggressive type of lung cancer. NSCLC the most common type of lung cancer. It is most often caused by exposure to tobacco smoke. The World Health Organization (WHO) estimates that NSCLC is responsible for about 880,000 deaths each year. Lung cancer is the leading cause of cancer deaths in the United States. The American Cancer Society estimates that lung cancer is responsible for 28% of cancer deaths or the deaths of more than 160,000 individuals annually. Erlotinib is not a first-line treatment for NSCLC, and is used only after the cancer has failed to respond or stopped responding to at least one round of chemotherapy.

Chemical Name: N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride; 6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; Tarceva.

CAS No.:[183319-69-9]

Appearance: Off- white Solid.

Related substances:Total impurities:1.0%max; Individual impurity:0.5%max.

Loss on Drying: max0.5%, Purity (HPLC):min99%


You can contact us if you want to order this product.